Christopher Andrew Young

Address:

1931 Dovershire Ct, Chesterfield, MO 63017

VIN:

1GNFK163X7J268450

Make:

CHEVROLET

Model:

SUBURBAN

Year:

2007

US Patent:

7553855, Jun 30, 2009

Filed:

May 14, 2007

Appl. No.:

11/748073

Inventors:

Christopher R. Young - Waltham MA, US
Charles William Rowe - Medford MA, US

Assignee:

Vertex Pharmaceuticals Incorporated - Cambridge MA

International Classification:

A61K 31/47

US Classification:

514312

Abstract:

Pharmaceutical compositions including N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 1) and methods of using such compositions are described herein.

US Patent:

8076357, Dec 13, 2011

Filed:

May 26, 2009

Appl. No.:

12/471950

Inventors:

Christopher R. Young - Waltham MA, US
Charles William Rowe - Medford MA, US

Assignee:

Vertex Pharmaceuticals Incorporated - Cambridge MA

International Classification:

A61K 31/47

US Classification:

514312

Abstract:

Pharmaceutical compositions including N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 1) and methods of using such compositions are described herein.

US Patent:

8552034, Oct 8, 2013

Filed:

Apr 7, 2011

Appl. No.:

13/081750

Inventors:

Marinus Jacobus Verwijs - Framingham MA, US
Ritu Rohit Kaushik - Watertown MA, US
Irina Nikolaevna Kadiyala - Newton MA, US
Christopher Young - Waltham MA, US

Assignee:

Vertex Pharmaceuticals Incorporated - Cambridge MA

International Classification:

A61K 31/443
C07D 405/12

US Classification:

514338, 5462837

Abstract:

A pharmaceutical composition comprising Compound 1, (3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid), and at least one excipient selected from: a filler, a diluent, a disintegrant, a surfactant, a binder, a glidant and a lubricant, the composition being suitable for oral administration to a patient in need thereof to treat a CFTR mediated disease such as Cystic Fibrosis. Methods for treating a patient in need thereof include administering an oral pharmaceutical formulation of Compound 1 to the patient.

US Patent:

20020130894, Sep 19, 2002

Filed:

Mar 15, 2001

Appl. No.:

09/809618

Inventors:

Christopher Young - Waltham MA, US
Michael Langlie - Belmont MA, US

International Classification:

G06F003/00

US Classification:

345/706000, 345/764000

Abstract:

A computer-implemented system includes generating a character and an object on a portion of a World Wide Web page, causing the character to interact with the object in response to a user input, and controlling movement of the character based on identities of the character and the object. An environment, such as a room, may also be generated for the character and the object. The environment houses the character and the object.

US Patent:

20100074949, Mar 25, 2010

Filed:

Aug 13, 2009

Appl. No.:

12/583066

Inventors:

William Rowe - Medford MA, US
Patricia Hurter - Harvard MA, US
Christopher Young - Waltham MA, US
Kirk Dinehart - Holliston MA, US
Marinus Jacobus Verwijs - Framingham MA, US
Kirk Overhoff - Waltham MA, US
Peter D.J. Grootenhuis - San Diego CA, US
Martyn Botfield - Concord MA, US
Alfredo Grossi - Somerville MA, US

International Classification:

A61K 9/28
A61K 31/47
A61K 9/42
A61K 9/44
A61P 3/00
A61P 19/10

US Classification:

424467, 514312, 424474, 424476

Abstract:

The present invention relates to pharmaceutical compositions comprising a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, methods of manufacturing pharmaceutical compositions of the present invention, and methods of administering pharmaceutical compositions of the present invention.

US Patent:

20100087490, Apr 8, 2010

Filed:

Sep 29, 2009

Appl. No.:

12/568717

Inventors:

Christopher Young - Waltham MA, US

Assignee:

VERTEX PHARMACEUTICALS INCORPORATED - Cambridge MA

International Classification:

A61K 31/443
C07D 405/12
A61P 43/00

US Classification:

514338, 5462837

Abstract:

The present invention relates to formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid in Form I, pharmaceutical packs or kits thereof, and methods of treatment therewith.

US Patent:

20100256184, Oct 7, 2010

Filed:

Feb 18, 2010

Appl. No.:

12/708359

Inventors:

William Rowe - Medford MA, US
Patricia Hurter - Harvard MA, US
Christopher R. Young - Waltham MA, US
Kirk Dinehart - Holliston MA, US
Marinus Jacobus Verwijs - Framingham MA, US
Kirk Overhoff - Waltham MA, US
Peter D.J. Grootenhuis - San Diego CA, US
Martyn Botfield - Concord MA, US
Alfredo Grossi - Somerville MA, US
Gregor Zlokarnik - La Jolla CA, US
Fredrick F. Van Goor - San Diego CA, US

Assignee:

Vertex Pharmaceuticals Incorporated - Cambridge MA

International Classification:

A61K 31/47
A61P 19/10
A61P 19/08
A61P 11/00

US Classification:

514312

Abstract:

The present invention relates to pharmaceutical compositions comprising a solid dispersion of N-[2,4-Bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide, methods of manufacturing pharmaceutical compositions of the present invention, and methods of administering pharmaceutical compositions of the present invention.

US Patent:

20110258302, Oct 20, 2011

Filed:

Apr 20, 2010

Appl. No.:

12/763350

Inventors:

David Alan Cole - St. Louis MO, US
James Ward Goddard - Ballwin MO, US
Christopher Young - Wildwood MO, US

International Classification:

G06F 15/173
G06F 17/30

US Classification:

709223, 707769, 707E17014

Abstract:

A system and method for uniquely identifying computer and support infrastructure equipment in a rack and to determine the physical location of the equipment within the rack. In one embodiment, a set of communication ports is installed in the rack, with each communication port representing a physical rack location unit. The equipment is queried via the equipment's communication port, which is coupled to one of the communication ports in the rack. Equipment which does not support identification through some protocol has its identification information stored in an intelligent device which can be queried through the same set of communication ports. A management module collects the equipment information and location and aggregates the information for the entire rack. This information can then be queried by a remotely over the network.